Join Now

Yearly Archives: 2022

MDUFA V Agreement Reached

The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for MDUFA V. On March 22, FDA sent the commitment letter to Congress. Under the new agreement, the FDA would be authorized to collect at least $1.78 billion in user fees over five years. FDA could receive additional funding […]

Posted in Policy News | Leave a comment

Pfizer’s $7B bet delivers phase 3 success, advancing bid to establish new drug in ulcerative colitis Arena

Pfizer’s $6.7 billion bet on Arena Pharmaceuticals has delivered a phase 3 success.

Posted in BioUtah News | Tagged | Leave a comment

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Recursion reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2021.

Posted in BioUtah News | Tagged | Leave a comment

FierceBiotech recognizes Recursion as the #2 Biotech IPO of 2021!

FierceBiotech Special Report: The top 10 biotech IPOs of 2021

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics Reports Full Year 2021 Financial Results

Achieved Record Full Year Revenue of $97.9 Million; Strength in Sales Momentum Provides Foundation to Achieve Solid FY’22

Posted in BioUtah News | Tagged , | Leave a comment

WATCH THE EXIM BANK & STEP GRANT FUNDS 101 WEBINAR REPLAY

WTC UTAH HAS A RECORD $1M+ TO ADMINISTER TO UTAH SMALL BUSINESSES. Learn from World Trade Center Utah, Meridian Finance Group, and the U.S. Small Business Administration (SBA) about export programs through the Export-Import Bank of the United States (EXIM) and how State Trade Expansion Program (STEP) funds can be used for those programs as a new eligible expense.

Posted in BioUtah News | Leave a comment

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

Posted in BioUtah News | Tagged , | Leave a comment

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution

Posted in BioUtah News | Tagged | Leave a comment

Pfizer Completes Acquisition of Arena Pharmaceuticals

Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces $5.0 Million Registered Direct Offering

PolarityTE Announces $5.0 Million Registered Direct Offering

Posted in BioUtah News | Tagged | Leave a comment